Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2020 $ 49,932 $ 373 $ 245,067 $ (147) $ (2,137) $ (193,224)
Beginning balance, Shares at Jan. 31, 2020   37,303,952        
Issuance of common stock pursuant to vesting of restricted stock units   $ 4 (4)      
Issuance of common stock pursuant to vesting of restricted stock units, Shares   379,063        
Issuance of common stock pursuant to ESPP purchases 18   18      
Issuance of common stock pursuant to ESPP purchases, shares   5,702        
Issuance of common stock pursuant to exercise of stock options 119   119      
Issuance of common stock pursuant to exercise of stock options, shares   39,270        
Stock-based compensation expense 617   617      
Repurchases of common stock (80)     (80)    
Unrealized gain(losses) on marketable securities (4)       (4)  
Foreign currency translation adjustment 1,641       1,641  
Net income (loss) (12,276)         (12,276)
Ending balance at Jul. 31, 2020 39,967 $ 377 245,817 (227) (500) (205,500)
Ending balance, Shares at Jul. 31, 2020   37,727,987        
Beginning balance at Apr. 30, 2020 43,901 $ 376 245,558 (147) (2,152) (199,734)
Beginning balance, Shares at Apr. 30, 2020   37,661,641        
Issuance of common stock pursuant to vesting of restricted stock units   $ 1 (1)      
Issuance of common stock pursuant to vesting of restricted stock units, Shares   66,346        
Stock-based compensation expense 260   260      
Repurchases of common stock (80)     (80)    
Unrealized gain(losses) on marketable securities (13)       (13)  
Foreign currency translation adjustment 1,665       1,665  
Net income (loss) (5,766)         (5,766)
Ending balance at Jul. 31, 2020 39,967 $ 377 245,817 (227) (500) (205,500)
Ending balance, Shares at Jul. 31, 2020   37,727,987        
Beginning balance at Jan. 31, 2021 31,541 $ 378 246,446 (227) (73) (214,983)
Beginning balance, Shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of restricted stock units   $ 10 (10)      
Issuance of common stock pursuant to vesting of restricted stock units, Shares   981,927        
Issuance of common stock pursuant to exercise of stock options 137 $ 1 136      
Issuance of common stock pursuant to exercise of stock options, shares   95,538        
Issuance of common stock, net of issuance costs 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 1,041   1,041      
Unrealized gain(losses) on marketable securities 1       1  
Foreign currency translation adjustment (358)       (358)  
Net income (loss) (3,841)         (3,841)
Ending balance at Jul. 31, 2021 45,983 $ 492 264,972 (227) (430) (218,824)
Ending balance, Shares at Jul. 31, 2021   49,212,173        
Beginning balance at Apr. 30, 2021 45,322 $ 484 264,147 (227) (31) (219,051)
Beginning balance, Shares at Apr. 30, 2021   48,408,342        
Issuance of common stock pursuant to vesting of restricted stock units   $ 8 (8)      
Issuance of common stock pursuant to vesting of restricted stock units, Shares   803,831        
Stock-based compensation expense 833   833      
Foreign currency translation adjustment (399)       (399)  
Net income (loss) 227         227
Ending balance at Jul. 31, 2021 $ 45,983 $ 492 $ 264,972 $ (227) $ (430) $ (218,824)
Ending balance, Shares at Jul. 31, 2021   49,212,173